Roman Yelensky, PhD
Roman Yelensky, PhD
Director, Clinical Genomic Analysis
Foundation Medicine Inc.
150 Second Street
Cambridge,
MA
USA
02141
Papers:
Tumor BRCA mutation or high genomic LOH identify ovarian cancer patients likely to respond to rucaparib: interim results for ARIEL2 clinical trial